[{"NetIncomeLoss_1_Q3_USD":-24903000.0,"Liabilities_0_Q3_USD":30746000.0,"RevenueFromRelatedParties_3_Q3_USD":0.0,"RevenueFromRelatedParties_1_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"GeneralAndAdministrativeExpense_3_Q3_USD":21867000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":7102000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":10323000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":45000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":18122000.0,"IncomeTaxesPaid_3_Q3_USD":45000.0,"HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue_0_Q3_USD":0.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":14466000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":79029000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":11.36,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1206000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":1000.0,"AssetsCurrent_0_Q3_USD":107457000.0,"OtherNoncashIncomeExpense_3_Q3_USD":1000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":37203000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7265000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":7409000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":348000.0,"CommonStockSharesIssued_0_Q3_shares":34287000.0,"Assets_0_Q3_USD":135833000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q3_USD":8.09,"Depreciation_3_Q3_USD":2601000.0,"ShareBasedCompensation_3_Q3_USD":7722000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":67103000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":411000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":1378000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":58671000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":18002000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":8.39,"EarningsPerShareBasic_3_Q3_USD":-2.33,"EarningsPerShareBasic_1_Q3_USD":-0.73,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":116287000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-88000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-9000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":34159000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":34081000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q3_shares":4381000.0,"OtherAssetsNoncurrent_0_Q3_USD":3678000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":1238000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":14000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":2000.0,"CommonStockValue_0_Q3_USD":34000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":1034000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":155000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":1961000.0,"HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q3_USD":1400000.0,"RestrictedCash_0_Q3_USD":1270000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_3_Q3_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-79323000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-24991000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":203000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":0.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":15567000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":13862000.0,"CommonStockSharesOutstanding_0_Q3_shares":34287000.0,"EarningsPerShareDiluted_3_Q3_USD":-2.33,"EarningsPerShareDiluted_1_Q3_USD":-0.73,"RestrictedCashNoncurrent_0_Q3_USD":1300000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":46000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2461000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-67128000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":34081000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":34159000.0,"LiabilitiesCurrent_0_Q3_USD":16280000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q3_USD":13627000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-186473000.0,"AccountsPayableCurrent_0_Q3_USD":2707000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3210000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":447000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":231000.0,"AdditionalPaidInCapital_0_Q3_USD":291481000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":100000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q3_shares":75000.0,"OperatingLeasePayments_3_Q3_USD":2924000.0,"IncomeLossAttributableToParent_3_Q3_USD":-79300000.0,"IncomeLossAttributableToParent_1_Q3_USD":-24901000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":8097000.0,"NetIncomeLoss_3_Q3_USD":-79314000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":68373000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":8485000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":6686000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":68000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":1514000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":4.23,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":4.35,"CommonStockSharesAuthorized_0_Q3_shares":160000000.0,"OperatingIncomeLoss_3_Q3_USD":-80538000.0,"OperatingIncomeLoss_1_Q3_USD":-25104000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":37144000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":400000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q3_USD":400000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":6.65,"PreferredStockValue_0_Q3_USD":0.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-100000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":4.5,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":5339000.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":7722000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2461000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":11300000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":3176000.0,"OperatingExpenses_3_Q3_USD":80538000.0,"OperatingExpenses_1_Q3_USD":25104000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":1358000.0,"OtherLiabilitiesCurrent_0_Q3_USD":74000.0,"StockholdersEquity_0_Q3_USD":105087000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":55000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":135833000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":4753000.0,"Ticker":"JNCE","CIK":"1640455","name":"JOUNCE THERAPEUTICS, INC.","OfficialName":"Jounce Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"354419760.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201106"}]